Pediatrix Medical sees FY25 Adjusted EBITDA $215M-$235M
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 20 2025
0mins
- Pediatrix's Financial Outlook: Pediatrix expects its Adjusted EBITDA for 2025 to be between $215 million and $235 million.
- Preliminary Estimates: The figures provided are preliminary estimates, indicating the company's projected financial performance.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy MD?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on MD
Wall Street analysts forecast MD stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MD is 23.50 USD with a low forecast of 23.00 USD and a high forecast of 24.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Analyst Rating
2 Buy
1 Hold
0 Sell
Moderate Buy
Current: 21.000
Low
23.00
Averages
23.50
High
24.00
Current: 21.000
Low
23.00
Averages
23.50
High
24.00
About MD
Pediatrix Medical Group, Inc. is a provider of physician services, including newborn, maternal-fetal, and other pediatric subspecialty care. The Company’s affiliated clinicians provide services to women, babies and children across the continuum of care, both in hospital settings and office-based practices. Its specialties include obstetrics, maternal-fetal medicine and neonatology, complemented by pediatric subspecialties. It offers specialized and critical care services through approximately 4,400 affiliated physicians and other clinicians. It provides neonatal clinical care, primarily within hospital-based neonatal intensive care units (NICUs), to babies born prematurely or with medical complications. The Company provides maternal-fetal and obstetrical medical care to expectant mothers experiencing complicated pregnancies primarily in areas where its affiliated neonatal physicians practice.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Midland Exploration Inc. Initiates 1,600-Metre Drilling Program on Jouvex Gold Property
- Drilling Program Launch: Midland Exploration has initiated a 1,600-metre drilling program on its Jouvex gold property, aimed at testing magnetic anomalies associated with IP anomalies, which is expected to provide crucial data on the area's gold potential.
- Historical Data Reevaluation: By reassessing historical drilling data, Midland has identified the southern part of the Jouvex project as the main area for current exploration efforts, indicating potential for VMS mineralization that may attract further investment.
- New Target Identification: In the southern project area, Midland has identified potential syenitic intrusions similar to the Douay gold deposit, which could become a key area for future gold development, further enhancing the company's strategic positioning.
- Partnerships: Midland has established partnerships with several reputable mining companies, demonstrating its strong intent to discover world-class gold and critical metal deposits in Quebec, which is expected to drive future growth for the company.
Continue Reading
Mid-Cap ETFs Experience Strong Momentum: Is Further Growth on the Horizon?
Mid-Cap Investing Appeal: Mid-cap stocks offer a balance of resilience and growth potential, currently showing strong performance with many ETFs reaching 52-week highs, despite the risks compared to large and small caps.
Global Economic Outlook: The IMF projects a decline in global growth rates, with developed economies growing slowly, which may lead investors to be cautious about large-cap stocks due to their foreign exposure.
Federal Reserve Actions: The Fed has implemented three rate cuts this year, with projections indicating a controlled outlook for GDP growth and unemployment rates, favoring domestically-focused stocks like small and mid-caps.
Mid-Cap ETFs Performance: Several mid-cap ETFs have outperformed the SPDR S&P 500 ETF Trust recently, with notable gains over the past month, suggesting a favorable investment opportunity in this segment.
Continue Reading